Literature DB >> 6848177

Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.

W E Berdel, E Greiner, U Fink, D Stavrou, A Reichert, J Rastetter, D R Hoffman, F Snyder.   

Abstract

Alkyl-lysophospholipids (ALP) and related derivatives inhibited the in vitro incorporation of [3H]thymidine into seven different permanent cell lines derived from rat brain tumors. The cytostatic effect of ALP was dependent on dosage and incubation time. Naturally occurring 2-lysophosphatidylcholine did not exhibit cytostatic effects; under these conditions, the incorporation rates of [3H]thymidine were generally more than 100% of the controls. The trypan blue dye exclusion test, which was used to assess severe cell damage, correlated with the extent that [3H]thymidine incorporation was inhibited by ALP. Preincubation of ALP (rac-1-octadecyl-lyso-glycero-3-phosphocholine) for more than 8 min with a tetrahydropteridine-dependent O-alkyl cleavage enzyme preparation from rat liver microsomes destroyed almost all of the cytotoxic properties of ALP when tested at a concentration that previously inhibited tumor growth by more than 50%. [3H]Thymidine incorporation rates were greater than 100% for astrocytoma cells incubated with ALP after exposure to the alkyl cleavage enzyme. Comparison of the microsomal activities of the tetrahydropteridine-dependent alkyl-cleavage enzyme present in astrocytoma 78-FR-G-299 cells and the pleomorphic glioma 78-FR-G-219/S4 cells to that found in normal skin fibroblasts and rat livers revealed a markedly reduced activity in the neoplastic cell lines. Moreover, those tumor cells that were more resistant to ALP cytotoxicity (pleomorphic glioma, 78-FR-G-219/S4) had a 3-fold higher tetrahydropteridine-dependent cleavage activity than a more cytotoxic sensitive line (astrocytoma cells, 78-FR-G-299). Our results indicate that the low-alkyl-cleavage enzyme activities in these neoplastic cells in comparison to normal cells might be a factor in explaining the relatively high cytotoxicity of ALP in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848177

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Pharmacokinetics and metabolism of a new antitumor semisynthetic ether phospholipid, 14C-labeled plasmanyl-(N-acyl)ethanolamine, in mice bearing sarcoma Mc11.

Authors:  J Kára; N I Zimakova; E A Serebryakova; V Dĕdková; A E Zolotaryov
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.

Authors:  L L Trulla; A Magistrelli; M Salmona; M T Tacconi
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

3.  Enzymatic acylation of ether and ester lysophospholipids in rat liver microsomes.

Authors:  W Neumüller; E A Fleer; C Unger; H Eibl
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

4.  Substrate specificity of O-alkylglycerol monooxygenase (E.C. 1.14.16.5), solubilized from rat liver microsomes.

Authors:  J Kötting; C Unger; H Eibl
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

5.  A continuous assay for O-alkylglycerol monooxygenase (E.C. 1.14.16.5).

Authors:  J Koetting; C Unger; H Eibl
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

6.  Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.

Authors:  H D Schick; W E Berdel; M Fromm; U Fink; U Jehn; K Ulm; A Reichert; H Eibl; C Unger; J Rastetter
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

7.  The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

Authors:  R W Wilcox; R L Wykle; J D Schmitt; L W Daniel
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

8.  Antitumor activity of SRI 62-834, a cyclic ether analog of ET-18-OCH3.

Authors:  W J Houlihan; M L Lee; P G Munder; G M Nemecek; D A Handley; C M Winslow; J Happy; C Jaeggi
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

9.  Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.

Authors:  W E Berdel; D D Von Hoff; C Unger; H D Schick; U Fink; A Reichert; H Eibl; J Rastetter
Journal:  Lipids       Date:  1986-04       Impact factor: 1.880

10.  Comparison of selective cytotoxicity of alkyl lysophospholipids.

Authors:  W R Vogler; A C Olson; S Okamoto; M Shoji; R L Raynor; J F Kuo; W E Berdel; H Eibl; J Hajdu; H Nomura
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.